Rchr
J-GLOBAL ID:201301080550537219   Update date: Nov. 20, 2024

Narimatsu Hiroto

ナリマツ ヒロト | Narimatsu Hiroto
Affiliation and department:
Job title: Division chief
Other affiliations (4):
  • Kanagawa Cancer Center  Department of Genetic Medicine   Director
  • Kanagawa University of Human Services  Graduate school of Health innovation   Professor
  • Kanagawa University of Human Services  Center for Innovation Policy 
  • CIKOP, Non-Profit Organization  Chairman
Homepage URL  (2): http://kcch.kanagawa-pho.jp/kccri/organization/yoboujouhou.htmlhttp://kcch.kanagawa-pho.jp/kccri/organization/yoboujouhou-en.html
Research field  (3): Internal medicine - General ,  Hygiene and public health (non-laboratory) ,  Nutrition and health science
Research keywords  (5): genomic medicine ,  cancer prevention ,  personalized medicine ,  clinical epidemiology ,  health innovation
Research theme for competitive and other funds  (34):
  • 2022 - 2028 Platform of Supporting Cohort Study and Biospecimen Analysis
  • 2023 - 2027 Community Interventions to Promote Physical Activity. Use of Multigenerational Composite Cohort Studies and Policy Development
  • 2023 - 2026 AI Chatbot を活用したAI遺伝カウンセリングの開発
  • 2022 - 2026 A comprehensive Mendelian Randomization on the causal pathway from psychological traits to all-cause mortality
  • 2022 - 2026 A comprehensive Mendelian Randomization on the causal pathway from psychological traits to all-cause mortality
Show all
Papers (181):
  • Yoichiro Okubo, Nagisa Toyama, Rika Kasajima, Soji Toda, Hiroyuki Hayashi, Emi Yoshioka, Kota Washimi, Shinya Sato, Yukihiko Hiroshima, Chie Hasegawa, et al. Effective Preparation of FFPE Tissue Samples for Preserving Appropriate Nucleic Acid Quality for Genomic Analysis in Thyroid Carcinoma. Endocrine pathology. 2024
  • Taizo Matsuki, Sho Nakamura, Minami Nishiyama, Hiroto Narimatsu. Holistic Evaluation of the Gut Microbiota through Data Envelopment Analysis: A Cross-Sectional Study. Current Developments in Nutrition. 2024. 8. 11. 104469-104469
  • Ryosuke Fujii, Asahi Hishida, Masahiro Nakatochi, Hiroshi Okumiyama, Naoyuki Takashima, Yoshiki Tsuboi, Koji Suzuki, Hiroaki Ikezaki, Chisato Shimanoe, Yasufumi Kato, et al. Polygenic risk score for blood pressure and lifestyle factors with overall and CVD mortality: a prospective cohort study in a Japanese population. Hypertension Research. 2024. 47. 9. 2284-2294
  • Yoshinobu Saito, Sho Nakamura, Takashi Kasukawa, Makoto Nagasawa, Yuko Oguma, Hiroto Narimatsu. Efficacy of exercise with the hybrid assistive limb lumbar type on physical function in mobility-limited older adults: A 5-week randomized controlled trial. Experimental gerontology. 2024. 112536-112536
  • Quyen An Tran, Sho Nakamura, Kaname Watanabe, Choy-Lye Chei, Hiroto Narimatsu. The relationship between loneliness and blood glucose: a cross-sectional survey among Japanese. BMC research notes. 2024. 17. 1. 201-201
more...
MISC (173):
  • 中村翔, 中村翔, 齋藤義信, 齋藤義信, 柳井美穂, 江藤真哉, 唐哉代, 成松宏人, 成松宏人, 成松宏人. 低糖質食事法とレジスタンス運動による介入プログラムと横断的BMIの遺伝学的リスクスコアとの関連の検証. 日本疫学会学術総会講演集(Web). 2024. 34th
  • Sho Nakamura, Hiroto Narimatsu. Data envelopment analysis for predicting pre-diabetes for primary disease prevention. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2021. 50
  • 菅沼 伸康, 山下 年成, 山中 隆司, 菅原 裕子, 松原 由佳, 戸田 宗治, 岡本 咲, 横瀬 智之, 河内 香江, 吉岡 恵美, et al. SPRECによる乳癌手術標本の品質管理. 日本乳癌学会総会プログラム抄録集. 2021. 29回. 39-39
  • 羽田恵梨, 佐藤杏, 谷島和美, 緒方文子, 山内桂子, 瀬畑善子, 瀬畑善子, 山中隆司, 清水哲, 成松宏人, et al. Dealing with single-parent cancer patients with hereditary tumors and her children. 日本遺伝カウンセリング学会誌. 2021. 42. 2. 126-126
  • 佐藤杏, 羽田恵梨, 成松宏人, 成松宏人, 成松宏人. 遺伝性腫瘍の診療におけるAI活用の可能性と今後の展望. 日本遺伝性腫瘍学会学術集会プログラム・抄録集. 2021. 27th
more...
Patents (2):
Books (2):
  • Microangiopathy
    InTech 2012 ISBN:9789535104193
  • Myeloid Leukemia - Clinical Diagnosis and Treatment
    InTech ISBN:9789533078861
Lectures and oral presentations  (142):
  • 未病改善を支える科学技術と専門家の力 (モデレーター)
    (ME-BYOサミット神奈川2024 2024)
  • サイエンスからの未病改善:「未病指標」 これからの展望
    (セッション3 未病改善を支える科学技術と専門家の力 ME-BYOサミット神奈川2024 2024)
  • シリーズ 学会発表に必要な研究の技法
    (日本海総合病院 2024)
  • Intervention Cohort Study, Novel Approach for Health Innovation
    (Singapore-Kanagawa Research meeting on Healthy Longevity 2024 2024)
  • シニアの健康・保健(未病)
    (シニア向けの講演会 シニアライフのキホンのキ 2024)
more...
Education (2):
  • 2005 - 2008 Nagoya University Graduate School of Medicine Hematology and Oncology
  • 1993 - 1999 Nagoya University School of Medicine
Professional career (2):
  • Ph.D. (Nagoya University)
  • M.D. ( Ministry of Health, Labour and Welfare of Japan)
Work history (14):
  • 2023/04 - 現在 Kanagawa University of Human Services Center for Innovation Policy
  • 2019/04 - 現在 Kanagawa University of Human Services Graduate school of Health innovation Professor
  • 2017/04 - 現在 Kanagawa Cancer Center Department of Genetic Medicine Director
  • 2015/04 - 現在 Kanagawa Cancer Center, Research Institute Cancer Prevention and Control Division Division chief
  • 2015/02 - 現在 CIKOP, Specified Nonprofit Corporation
Show all
Committee career (9):
  • 2023/04 - 現在 国立がん研究センター 都道府県がん診療連携拠点病院連絡協議会 がん登録部会委員
  • 2019/04 - 現在 神奈川県 神奈川ME-BYOリビングラボ専門委員
  • 2016/06 - 現在 神奈川県生活習慣病対策委員会 がん・循環器病対策部会
  • 2016/06 - 現在 神奈川県 神奈川県生活習慣病対策委員会
  • 2024/02 - 2025/03 Study Group for the Kanagawa Functional Demonstration Project of the ME-BYO Conditioning Center Chirman
Show all
Awards (3):
  • 2023/03 - Hamagin Foundation Hamagin Foundation Frontiers Special Prize, the 3rd Hamagin Foundation Grant for Social Implementation of Technology Seeds Development of AI-based genetic counseling system and business development
  • 2015/02 - Yamagata Medical Society Award for Social Achievement, Yamagata Medical Society
  • 2013/02 - Silver Scientific Award, Yamagata Medical Society Constructing a contemporary gene-environmental cohort: study design of the Yamagata Molecular Epidemiological Cohort Study
Association Membership(s) (8):
日本公衆衛生学会 ,  日本遺伝性腫瘍学会 ,  日本癌学会 ,  日本疫学会 ,  日本人類遺伝学会 ,  日本臨床腫瘍学会 ,  日本血液学会 ,  日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page